Trials / Completed
CompletedNCT00195429
A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients
A Randomized, Open-label and Multicenter Trial Comparing Withdrawal of Steroids or Tacrolimus From Sirolimus-based Immunosuppressive Regimen in de Novo Renal Allograft Recipients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates two different immunosuppression drug regimens in patients with a recent kidney transplant. Patients initially received a regimen of Sirolimus, Tacrolimus and Prednisone and then randomized to discontinue either Tacrolimus or Prednisone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus | |
| DRUG | Sirolimus | |
| DRUG | prednisone |
Timeline
- Start date
- 2005-08-01
- Completion
- 2007-10-01
- First posted
- 2005-09-19
- Last updated
- 2023-12-11
- Results posted
- 2009-06-02
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00195429. Inclusion in this directory is not an endorsement.